Clinical characteristics of COVID-19 infection in polyhandicapped persons in France.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 09 11 2020
revised: 29 03 2021
accepted: 16 04 2021
pubmed: 18 5 2021
medline: 25 6 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

Little is known about the clinical profile of COVID-19 infection in polyhandicapped persons. This study aimed to describe the characteristics of this infection among individuals with polyhandicap. This was a retrospective observational study. Polyhandicap was defined by the combination of motor deficiency, profound mental retardation, and age at onset of cerebral lesion younger than 6 years. A positive COVID-19 status was considered for patients with a positive COVID-19 laboratory test result, or patients presenting with compatible symptoms and living in an institution or at home with other patients or relatives who had laboratory-confirmed COVID-19 infection. Data collection included sociodemographic data, clinical and paraclinical characteristics, as well as the management and treatment for COVID-19 infection. We collected 98 cases, with a sex ratio of 0.98 and a mean age of 38.5 years (3 months to 73 years). COVID-19 infection was paucisymptomatic in 46% of patients, 20.6% of patients presented with dyspnea, while the most frequent extra-respiratory symptoms were digestive (26.5%) and neurological changes (24.5%); 18 patients required hospital admission, four adults died. The mean duration of infection was longer for adults than for children, and the proportion of taste and smell disorders was higher in older patients. These findings suggest that PLH persons often develop paucisymptomatic forms of COVID-19 infection, although they may also experience severe outcomes, including death. Clinicians should be aware that COVID-19 symptoms in PLH persons are often extra-respiratory signs, mostly digestive and neurologic, which may help in the earlier identification of COVID-19 infection in this particular population of patients.

Identifiants

pubmed: 33994267
pii: S0929-693X(21)00084-1
doi: 10.1016/j.arcped.2021.04.004
pmc: PMC8064873
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

374-380

Informations de copyright

Copyright © 2021 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

M-C Rousseau (MC)

Service polyhandicap adultes, Hôpital San Salvadour (Assistance Publique Hôpitaux de Paris), BP 30 080, 83407 Hyères cedex, France. Electronic address: marie-christine.rousseau@aphp.fr.

M Hully (M)

MD, Services de Neurologie et Rééducation Pédiatriques, Hôpital Necker Enfants Malades, APHP, 75015 Paris, France.

M Milh (M)

Service de Neuropédiatrie, Hôpital d'Enfants CHU Timone, 13005 Marseille, France.

D Juzeau (D)

Santé Publique, Co Fondatrice du réseau NeurodeV, 59000 Lille, France.

B Pollez (B)

APEI Lille, 59000 Lille, France.

S Peudenier (S)

CRDI, Hôpital Morvan, CHRU Brest, 29200 Brest, France.

N Bahi Buisson (N)

Pediatric Neurology, Necker Enfants Malades University Hospital, Université de Paris, 75015 Paris, France; Institut Imagine, INSERM U 1163, Université de Paris, Paris, France.

V Gautheron (V)

Physical and Rehabilitation Medicine, Bellevue University Hospital, 42100 Saint-Étienne, France.

B Chabrol (B)

Service de Neuropédiatrie, Hôpital d'Enfants CHU Timone, 13005 Marseille, France.

T Billette de Villemeur (T)

Service de Neuropédiatrie, Pathologie du développement, hôpital Trousseau-La Roche Guyon, 95780 La Roche-Guyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH